William Blair Has Bearish Forecast for BMY FY2026 Earnings
Equities research analysts at William Blair decreased their FY2026 earnings per share estimates for shares of Bristol-Myers ...
William Blair Has Bullish Forecast for MOD FY2025 Earnings
Equities research analysts at William Blair upped their FY2025 EPS estimates for shares of Modine Manufacturing in a note ...
American Banker21h
Affirm's 0% loans, cards, chart a path to profitability
The buy now/pay later lender outperformed nearly every analyst estimate in its fiscal Q2 2025 earnings report. CEO Max Levchin said the company is 5 months out from positive GAAP operating income.
Hosted on MSN22h
William Blair Initiates Coverage of Rubrik (RBRK) with Market Perform Recommendation
Fintel reports that on February 7, 2025, William Blair initiated coverage of Rubrik (NYSE:RBRK) with a Market Perform ...
Why Is Neurocrine Biosciences Stock Trading Lower On Friday?
Neurocrine Biosciences Q4 earnings topped forecasts, but revenue slightly missed. Analysts see Ingrezza's long-term growth ...